Literature DB >> 22980058

Renal dysfunction in heart failure.

Robert T Cole1, Amirali Masoumi, Filippos Triposkiadis, Gregory Giamouzis, Vasiliki Georgiopoulou, Andreas Kalogeropoulos, Javed Butler.   

Abstract

Renal dysfunction is a common, important comorbidity in patients with both chronic and acute heart failure (HF). Chronic kidney disease and worsening renal function (WRF) are associated with worse outcomes, but our understanding of the complex bidirectional interactions between the heart and kidney remains poor. When addressing these interactions, one must consider the impact of intrinsic renal disease resulting from medical comorbidities on HF outcomes. WRF may result from any number of important processes. Understanding the role of each of these factors and their interplay are essential in understanding how to improve outcomes in patients with renal dysfunction and HF.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22980058     DOI: 10.1016/j.mcna.2012.07.005

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  11 in total

1.  Association between chronic kidney disease progression and cardiovascular disease: results from the CRIC Study.

Authors:  Mahboob Rahman; Dawei Xie; Harold I Feldman; Alan S Go; Jiang He; John W Kusek; James Lash; Edgar R Miller; Akinlolu Ojo; Qiang Pan; Stephen L Seliger; Susan Steigerwalt; Ray R Townsend
Journal:  Am J Nephrol       Date:  2014-11-11       Impact factor: 3.754

Review 2.  The hemodynamic and nonhemodynamic crosstalk in cardiorenal syndrome type 1.

Authors:  Grazia Maria Virzì; Anna Clementi; Alessandra Brocca; Massimo de Cal; Giorgio Vescovo; Antonio Granata; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2014-05-14       Impact factor: 2.041

Review 3.  Epidemiology and importance of renal dysfunction in heart failure patients.

Authors:  Gregory Giamouzis; Andreas P Kalogeropoulos; Javed Butler; Georgios Karayannis; Vasiliki V Georgiopoulou; John Skoularigis; Filippos Triposkiadis
Journal:  Curr Heart Fail Rep       Date:  2013-12

4.  Myocardial infarction worsens glomerular injury and microalbuminuria in rats with pre-existing renal impairment accompanied by the activation of ER stress and inflammation.

Authors:  Zhifeng Dong; Penglong Wu; Yongguang Li; Yuan Shen; Ping Xin; Shuai Li; Zhihua Wang; Xiaoyan Dai; Wei Zhu; Meng Wei
Journal:  Mol Biol Rep       Date:  2014-08-31       Impact factor: 2.316

5.  Demographical and clinicopathological characteristics in heart failure and outcome predictors: a prospective, observational study.

Authors:  Chakanalil Govindan Sajeev; Shreetal Rajan Nair; Biju George; Gopalan Nair Rajesh; Mangalath Narayanan Krishnan
Journal:  ESC Heart Fail       Date:  2016-10-07

Review 6.  Insights of Worsening Renal Function in Type 1 Cardiorenal Syndrome: From the Pathogenesis, Biomarkers to Treatment.

Authors:  Kang Fu; Yue Hu; Hui Zhang; Chen Wang; Zongwei Lin; Huixia Lu; Xiaoping Ji
Journal:  Front Cardiovasc Med       Date:  2021-12-14

7.  Diagnostic Values of Blood Urea Nitrogen (BUN), Creatinine (Cr), and the Ratio of BUN to Cr for Distinguishing Heart Failure from Asthma and Chronic Obstructive Pulmonary Disease.

Authors:  Jingjing Zhang; Ling Zhou; Yuezhan Zhang
Journal:  Comput Math Methods Med       Date:  2022-07-21       Impact factor: 2.809

8.  Cardio-renal benefits of sacubitril/valsartan in patients with advanced chronic kidney disease: experience in daily clinical practice.

Authors:  María Dolores Martínez-Esteban; Teresa Vázquez-Sánchez; Daniel Gaitán-Román; Domingo Hernández; Rafael Pozo-Álvarez; Alicia Moreno-Ortiz; Juana Alonso-Titos; Guillermo Martín-Reyes; Pedro Ruiz-Esteban
Journal:  BMC Nephrol       Date:  2022-08-23       Impact factor: 2.585

9.  Involvement of Cyclic Guanosine Monophosphate-Dependent Protein Kinase I in Renal Antifibrotic Effects of Serelaxin.

Authors:  Veronika Wetzl; Elisabeth Schinner; Frieder Kees; Franz Hofmann; Lothar Faerber; Jens Schlossmann
Journal:  Front Pharmacol       Date:  2016-07-12       Impact factor: 5.810

10.  Cystatin C for predicting all-cause mortality and rehospitalization in patients with heart failure: a meta-analysis.

Authors:  Shenghua Chen; Yangzhang Tang; Xueyin Zhou
Journal:  Biosci Rep       Date:  2019-02-05       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.